Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q3 2013 (← Previous) (Next →)
Filing Date: Nov 14, 2013
Total Value: $7.036B (80.3% shares, 19.7% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Pharmacyclics Inc. | 9,010,211 | $1.246B | 17.7% | $79.47 | — | COM | 716933106 |
| — | Seattle Genetics Inc. | 19,322,947 | $847M | 12.0% | $31.46 | — | COM | 812578102 |
| — | Incyte Genomics Notes 4.75% 10/1/2015 | 157,758,000 | $688M | 9.8% | $2.55 | — | CONV BONDS | 45337CAH5 |
| — | Synageva Biopharma Corp. | 10,273,182 | $651M | 9.3% | $44.17 | — | COM | 87159A103 |
| INCY | Incyte Corp. | 14,810,559 | $565M | 8.0% | $21.85 | +35.1% | COM | 45337C102 |
| ACAD | Acadia Pharmaceuticals Inc. | 19,955,126 | $548M | 7.8% | $13.77 | +51.8% | COM | 004225108 |
| — | Genomic Health Inc. | 13,650,835 | $417M | 5.9% | $31.71 | — | COM | 37244C101 |
| — | Salix 2.75% 5/15/15 | 219,440,000 | $335M | 4.8% | $1.52 | — | CONV BONDS | 795435AC0 |
| — | Viropharma Inc. | 5,592,239 | $220M | 3.1% | $28.65 | — | COM | 928241108 |
| — | Xoma Corp. | 23,032,372 | $103M | 1.5% | $3.73 | — | COM | 98419J107 |
| — | Auxilium 1.5% 7/15/2018 | 87,090,000 | $90.25M | 1.3% | $0.96 | — | CONV BONDS | 05334DAA5 |
| — | Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | 22,898,000 | $82.03M | 1.2% | $2.76 | — | CONV BONDS | 09061GAD3 |
| GILD | Gilead Sciences Inc. | 1,245,800 | $78.32M | 1.1% | $36.21 | +14.7% | COM | 375558103 |
| HALO | Halozyme Therapeutics Inc. | 7,017,608 | $77.47M | 1.1% | $6.50 | +28.2% | COM | 40637H109 |
| — | Repros Therapeutics | 2,778,654 | $74.47M | 1.1% | $18.45 | — | COM | 76028H209 |
| — | Aegerion Pharmaceuticals | 820,275 | $70.34M | 1.0% | $63.34 | — | COM | 00767E102 |
| — | Gilead 1.625% 5/1/16 | 21,500,000 | $59.53M | 0.8% | $2.26 | — | CONV BONDS | 375558AP8 |
| — | Intermune Inc Notes 2.5% 12/15/17 | 41,000,000 | $58.42M | 0.8% | $1.07 | — | CONV BONDS | 45884XAF0 |
| CERS | Cerus | 8,455,306 | $56.82M | 0.8% | $4.84 | +12.3% | COM | 157085101 |
| BMRN | Biomarin Pharmaceuticals | 783,311 | $56.53M | 0.8% | $62.32 | +6.6% | COM | 09061G101 |
| — | Medivation 2.625% 4/1/17 | 39,500,000 | $55.56M | 0.8% | $1.27 | — | CONV BONDS | 58501NAA9 |
| VNDA | Vanda Pharmaceuticals, Inc. | 4,791,179 | $52.46M | 0.7% | $7.41 | +44.1% | COM | 921659108 |
| BCRX | Biocryst Pharmaceuticals Inc. | 6,699,979 | $48.78M | 0.7% | $2.29 | +121.2% | COM | 09058V103 |
| — | Stemline Therapeutics Inc. | 800,400 | $36.26M | 0.5% | $23.84 | — | COM | 85858C107 |
| — | Derma Sciences | 2,558,857 | $31.68M | 0.5% | $12.90 | — | COM | 249827502 |
| — | Questcor Pharmaceuticals, Inc. | 545,846 | $31.66M | 0.4% | $50.73 | — | COM | 74835Y101 |
| — | Mirati Therapeutics Inc. | 1,980,074 | $30M | 0.4% | $15.15 | — | COM | 60468T105 |
| — | Intercept Pharmaceuticals, Inc. | 362,847 | $25.05M | 0.4% | $44.84 | — | COM | 45845P108 |
| — | Ariad Pharmaceuticals Inc. | 1,333,703 | $24.54M | 0.3% | $17.49 | — | COM | 04033A100 |
| — | Medivation Inc. | 398,331 | $23.88M | 0.3% | $49.20 | — | COM | 58501N101 |
| — | Progenics Pharmaceuticals, Inc. | 4,200,000 | $21.08M | 0.3% | $4.46 | — | COM | 743187106 |
| — | Intermune Inc Notes 5% 3/1/15 | 16,860,000 | $20.04M | 0.3% | $1.05 | — | CONV BONDS | 45884XAD5 |
| — | Avanir Pharmaceuticals | 4,428,591 | $18.73M | 0.3% | $4.53 | — | COM | 05348P401 |
| — | Clovis Oncology | 301,744 | $18.35M | 0.3% | $66.98 | — | COM | 189464100 |
| — | Arrowhead Research Corp. | 3,140,000 | $17.87M | 0.3% | $5.69 | — | COM | 042797209 |
| — | Chelsea Therapeutics | 5,794,753 | $17.33M | 0.2% | $2.42 | — | COM | 163428105 |
| INSM | Insmed Inc. | 945,803 | $14.76M | 0.2% | $10.61 | +19.7% | COM | 457669307 |
| — | Kythera Biopharmaceuticals | 265,000 | $12.08M | 0.2% | $34.04 | — | COM | 501570105 |
| — | Synergy Pharmaceuticals | 2,608,271 | $11.92M | 0.2% | $4.32 | — | COM | 871639308 |
| — | Ambit Biosciences Corp. | 747,962 | $11.59M | 0.2% | $7.00 | — | COM | 02318X100 |
| — | Targacept | 2,068,186 | $10.98M | 0.2% | $5.31 | — | COM | 87611R306 |
| INFIQ | Infinity Pharmaceuticals Inc. | 586,936 | $10.23M | 0.1% | $30.95 | -38.1% | COM | 45665G303 |
| — | Idera Pharmaceuticals Inc. | 5,865,000 | $10.21M | 0.1% | $0.91 | — | COM | 45168K306 |
| — | Array Biopharma Inc. | 1,500,000 | $9.33M | 0.1% | $4.54 | — | COM | 04269X105 |
| — | Anacor Pharmaceuticals | 876,463 | $9.308M | 0.1% | $5.59 | — | COM | 32420101 |
| — | Isis Pharmaceuticals | 247,036 | $9.274M | 0.1% | $26.87 | — | COM | 464330109 |
| — | Threshold Pharma | 1,852,399 | $8.614M | 0.1% | $4.65 | — | COM | 885807206 |
| — | Portola Pharmaceuticals, Inc. | 299,911 | $8.023M | 0.1% | $24.57 | — | COM | 737010108 |
| PRTA | Prothena Corp. PLC | 369,650 | $7.478M | 0.1% | $9.30 | +90.2% | COM | G72800108 |
| — | QLT, Inc. | 1,535,863 | $7.111M | 0.1% | $4.39 | — | COM | 746927102 |
| — | Osiris Therapeutics Inc. | 375,282 | $6.245M | 0.1% | $16.64 | — | COM | 68827R108 |
| OMER | Omeros Corp | 608,404 | $5.932M | 0.1% | $5.96 | 0.0% | COM | 682143102 |
| — | Xenoport | 1,034,112 | $5.874M | 0.1% | $4.95 | — | COM | 98411C100 |
| AGIO | Agios Pharmaceuticals | 200,000 | $5.592M | 0.1% | $27.61 | 0.0% | COM | 00847X104 |
| IRWD | Ironwood Pharmaceuticals | 461,160 | $5.46M | 0.1% | $12.12 | -19.1% | COM | 46333X108 |
| — | Novavax | 1,716,913 | $5.408M | 0.1% | $3.15 | — | COM | 670002104 |
| PBYI | Puma Biotechnology | 100,000 | $5.366M | 0.1% | $38.36 | +40.5% | COM | 74587V107 |
| — | BioDelivery Sciences Intl. Inc. | 846,005 | $4.594M | 0.1% | $4.06 | — | COM | 09060J106 |
| UTHR | United Therapeutics Corp. | 55,984 | $4.414M | 0.1% | $73.09 | 0.0% | COM | 91307C102 |
| — | MEI Pharma, Inc. | 345,317 | $3.885M | 0.1% | $7.13 | — | COM | 55279B103 |
| — | Zogenix, Inc. | 2,001,000 | $3.704M | 0.1% | $1.71 | — | COM | 98978L105 |
| — | Ventrus Biosciences, Inc. | 1,215,840 | $3.514M | 0.0% | $2.40 | — | COM | 922822101 |
| GERN | Geron Corp. | 1,000,000 | $3.35M | 0.0% | $1.08 | +51.0% | COM | 374163103 |
| — | Ligand Pharmaceuticals Inc. | 73,400 | $3.177M | 0.0% | $37.40 | — | CLASS B | 53220K207 |
| — | Synta Pharmaceuticals | 500,000 | $3.155M | 0.0% | $4.99 | — | COM | 87162T206 |
| TGTX | TG Therapeutics | 600,000 | $3.024M | 0.0% | $6.12 | 0.0% | COM | 88322Q108 |
| — | Bluebird Bio Inc. | 111,521 | $3.007M | 0.0% | $26.96 | — | COM | 09609G100 |
| — | Discovery Laboratories Inc. | 1,518,617 | $2.976M | 0.0% | $1.52 | — | COM | 254668403 |
| ENTA | Enanta Pharmaceuticals | 125,000 | $2.865M | 0.0% | $19.50 | -2.0% | COM | 29251M106 |
| — | Receptos Inc. | 100,000 | $2.597M | 0.0% | $19.89 | — | COM | 756207106 |
| SGMO | Sangamo | 176,707 | $1.854M | 0.0% | $9.93 | 0.0% | COM | 800677106 |
| — | Rigel Pharmaceuticals | 500,000 | $1.79M | 0.0% | $3.58 | — | COM | 766559603 |
| OSUR | Orasure Technologies Inc. | 243,467 | $1.463M | 0.0% | $4.46 | +12.3% | COM | 68554V108 |
| — | Achillion | 455,000 | $1.374M | 0.0% | $8.18 | — | COM | 00448Q201 |
| — | Tesaro Inc. | 31,218 | $1.209M | 0.0% | $32.74 | — | COM | 881569107 |
| FOLD | Amicus Therapeutics | 515,072 | $1.195M | 0.0% | $3.07 | -18.4% | COM | 03152W109 |
| — | Chemocentryx Inc. | 200,000 | $1.112M | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Ziopharm Oncology Inc. | 254,199 | $1.002M | 0.0% | $2.11 | — | COM | 98973P101 |
| — | Epizyme Inc. | 20,000 | $800K | 0.0% | $28.15 | — | COM | 29428V104 |
| — | Cubist Pharmaceuticals Inc. | 5,000 | $318K | 0.0% | $48.20 | — | COM | 229678107 |
| — | Salix Pharmaceuticals, Inc. | 3,621 | $242K | 0.0% | $66.16 | — | COM | 795435106 |
| — | Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | 20,979 | $177K | 0.0% | $7.20 | — | PFD CONV EX | 23254L207 |